Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural Fibrinolysis and DNase versus VATS for the treatment of pleural empyema
2020-002484-60Phase 4Active
- Sponsor
- University Hospital Odense
- Start
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of tissue-plasminogen activator and dornase alfa in Empyema Thoracis (2 arms), sponsored by University Hospital Odense. Started May 2021; status: active.
02
Drugs
tissue-plasminogen activatordornase alfa
03
Conditions
Empyema Thoracis
Beyond the preview
Go deeper on 2020-002484-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002484-60.